Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.

Financial Strength

Name	Current	Vs Industry
Cash-To-Debt	240.14
Equity-to-Asset	0.8
Debt-to-EBITDA	0.02
Interest Coverage	225.2
Piotroski F-Score	9/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	9.65	Distress Grey Safe
WACC vs ROIC		WACC ROIC

Growth Rank

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	33.8
	3-Year Book Growth Rate	13.3

Momentum Rank

	Name	Current	Vs Industry		Vs History

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	5.05
	Quick Ratio	5.05
	Cash Ratio	4.3
	Days Sales Outstanding	48.63
	Days Payable	26.32

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Shareholder Yield %	0.16

Profitability Rank

	Name	Current	Vs Industry		Vs History
	Gross Margin %	65.8
	Operating Margin %	34.95
	Net Margin %	37.82
	FCF Margin %	60.85
	ROE %	25.09
	ROA %	20.15
	ROIC %	120.54
	ROC (Joel Greenblatt) %	1201.04
	ROCE %	31.39
	Years of Profitability over Past 10-Year	8

GF Value Rank

	Name	Current	Vs Industry		Vs History
	PE Ratio	9.2
	PE Ratio without NRI	9.2
	Price-to-Owner-Earnings	4.89
	PS Ratio	3.54
	PB Ratio	2.11
	Price-to-Tangible-Book	2.09
	Price-to-Free-Cash-Flow	5.9
	Price-to-Operating-Cash-Flow	5.75
	EV-to-EBIT	5.64
	EV-to-EBITDA	5.42
	EV-to-Revenue	2.69
	EV-to-FCF	4.42
	Price-to-Projected-FCF	1.44
	Price-to-Graham-Number	0.92
	Price-to-Net-Current-Asset-Value	2.09
	Price-to-Net-Cash	2.56
	Earnings Yield (Greenblatt) %	17.73
	FCF Yield %	17.16

Financials

Annual Quarterly TTM

XKLS:03006's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

No Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

No Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

No Enough Data

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

No Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015

Nova Pharma Solutions Bhd Executives

Details

GF Value: RM0.16

XKLS:03006

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 6 Good signs with 03006. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil RM)	9.664
	EPS (TTM) (RM)	0.025
	Beta	-0.03
	Volatility %	0
	14-Day RSI	0
	14-Day ATR (RM)	0
	20-Day SMA (RM)	0.23
	12-1 Month Momentum %	0
	52-Week Range (RM)	0.23 - 0.23
	Shares Outstanding (Mil)	149.01

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	9
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Nova Pharma Solutions Bhd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Nova Pharma Solutions Bhd Stock Events

Financials Calendars

	Event	Date	Price(RM)
No Event Data

Nova Pharma Solutions Bhd Frequently Asked Questions

What is Nova Pharma Solutions Bhd(XKLS:03006)'s stock price today?

The current price of XKLS:03006 is RM0.23. The 52 week high of XKLS:03006 is RM0.23 and 52 week low is RM0.23.

When is next earnings date of Nova Pharma Solutions Bhd(XKLS:03006)?

The next earnings date of Nova Pharma Solutions Bhd(XKLS:03006) is .

Does Nova Pharma Solutions Bhd(XKLS:03006) pay dividends? If so, how much?

Nova Pharma Solutions Bhd(XKLS:03006) does not pay dividend.

Press Release

	Subject	Date
No Press Release

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.